A phase 2, open-label study of the safety and efficacy of intravenous anidulafungin as a treatment for azole-refractory mucosal candidiasis

José A. Vazquez, Jennifer A. Schranz, Kay Clark, Beth P. Goldstein, Annette Reboli, Carl Fichtenbaum

Research output: Contribution to journalArticlepeer-review

35 Scopus citations

Fingerprint

Dive into the research topics of 'A phase 2, open-label study of the safety and efficacy of intravenous anidulafungin as a treatment for azole-refractory mucosal candidiasis'. Together they form a unique fingerprint.

Medicine & Life Sciences